Logo image of TMC

TMC THE METALS CO INC (TMC) Stock Fundamental Analysis

NASDAQ:TMC - Nasdaq - CA87261Y1060 - Common Stock - Currency: USD

4.6201  +0.28 (+6.45%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to TMC. TMC was compared to 155 industry peers in the Metals & Mining industry. Both the profitability and financial health of TMC have multiple concerns. TMC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

TMC had negative earnings in the past year.
TMC had a negative operating cash flow in the past year.
In the past 5 years TMC always reported negative net income.
TMC had a negative operating cash flow in each of the past 5 years.
TMC Yearly Net Income VS EBIT VS OCF VS FCFTMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

TMC has a worse Return On Assets (-119.93%) than 94.84% of its industry peers.
Industry RankSector Rank
ROA -119.93%
ROE N/A
ROIC N/A
ROA(3y)-139.17%
ROA(5y)-125.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMC Yearly ROA, ROE, ROICTMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600

1.3 Margins

TMC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMC Yearly Profit, Operating, Gross MarginsTMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

The number of shares outstanding for TMC has been increased compared to 1 year ago.
Compared to 5 years ago, TMC has more shares outstanding
The debt/assets ratio for TMC is higher compared to a year ago.
TMC Yearly Shares OutstandingTMC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
TMC Yearly Total Debt VS Total AssetsTMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

TMC has an Altman-Z score of -7.26. This is a bad value and indicates that TMC is not financially healthy and even has some risk of bankruptcy.
TMC has a worse Altman-Z score (-7.26) than 92.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.26
ROIC/WACCN/A
WACCN/A
TMC Yearly LT Debt VS Equity VS FCFTMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

TMC has a Current Ratio of 0.13. This is a bad value and indicates that TMC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.13, TMC is not doing good in the industry: 94.84% of the companies in the same industry are doing better.
A Quick Ratio of 0.13 indicates that TMC may have some problems paying its short term obligations.
TMC has a worse Quick ratio (0.13) than 94.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
TMC Yearly Current Assets VS Current LiabilitesTMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.35% over the past year.
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

TMC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.38% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.75%
EPS Next 2Y20.33%
EPS Next 3Y39.02%
EPS Next 5Y56.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMC Yearly Revenue VS EstimatesTMC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 1B 2B 3B 4B 5B
TMC Yearly EPS VS EstimatesTMC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

1

4. Valuation

4.1 Price/Earnings Ratio

TMC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TMC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMC Price Earnings VS Forward Price EarningsTMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMC Per share dataTMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as TMC's earnings are expected to grow with 39.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.33%
EPS Next 3Y39.02%

0

5. Dividend

5.1 Amount

TMC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TMC THE METALS CO INC

NASDAQ:TMC (6/12/2025, 12:49:02 PM)

4.6201

+0.28 (+6.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners9.63%
Inst Owner Change9.36%
Ins Owners14.23%
Ins Owner Change5.23%
Market Cap1.67B
Analysts80
Price Target7.16 (54.98%)
Short Float %9.37%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.37%
Min EPS beat(2)-69.73%
Max EPS beat(2)0.99%
EPS beat(4)2
Avg EPS beat(4)-21.64%
Min EPS beat(4)-69.73%
Max EPS beat(4)0.99%
EPS beat(8)4
Avg EPS beat(8)-4.2%
EPS beat(12)6
Avg EPS beat(12)-1.75%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.98%
PT rev (3m)76.24%
EPS NQ rev (1m)-25.71%
EPS NQ rev (3m)-25.71%
EPS NY rev (1m)-12.82%
EPS NY rev (3m)-15.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS-0.05
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-139.17%
ROA(5y)-125.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.13%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -7.26
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)193.8%
Cap/Depr(5y)134.06%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y40.75%
EPS Next 2Y20.33%
EPS Next 3Y39.02%
EPS Next 5Y56.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.74%
EBIT Next 3Y46.44%
EBIT Next 5Y101.4%
FCF growth 1Y45.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.08%
OCF growth 3YN/A
OCF growth 5YN/A